Denmark· DK-28106252319
Amikacin "Macure"
A amikacin product containing amikacinsulfat, registered in Denmark by Macure Pharma ApS. The same ATC class is registered in 15 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Amikacin is registered in 15 of 19 countries.
Countries holding a registration under ATC J01GB06 (amikacin), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 8 of them publish a price we can compare per daily dose
Amikacin · ATC J01GB06
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Amikacinsulfat
- Manufacturer
- Macure Pharma ApS
- Country
- Denmark (DK)
- ATC code
- J01GB06
- ATC class
- Amikacin
- Defined daily dose
- 0.59 g, Inhal
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106252319
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
253 interactions on record for amikacin.
Graded by severity as the source publishes them — 50 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Amikacin · interactions on record
253 records
- 50 severe
- 133 moderate
- 2 minor
- 68 info
Most severe, free to view
- Magnesium sulfateA06AD04severe
- MannitolA06AD16severe
- Polymyxin BA07AA05severe
- Magnesium sulfateA12CC02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under J01GB06
Amikacin, as other registers publish it.
- DenmarkAmikacin "Afortas"2care4 Generics ApS
- DenmarkAmikacin "Medartuum"Medartuum AB
- DenmarkAmikacin "Orifarm"Orifarm A/S
- IrelandAmikacin 125 mg/ml Solution for injection/infusionNoridem Enterprises Limited
- IrelandAmikacin 250 mg/ ml Solution for injection/infusionAthlone Pharmaceuticals Limited
- IrelandAmikacin 250 mg/ml Solution for injection/infusionNoridem Enterprises Limited
- United KingdomAmikacin 25mg/5ml solution for injection ampoulesSpecial Order
- United KingdomAmikacin 25mg/5ml solution for injection pre-filled syringesSpecial Order
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/59ae6f73-2efc-4aa1-9b6a-acddbc39610a GET /v1/drugs/59ae6f73-2efc-4aa1-9b6a-acddbc39610a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "injektionsvæske, opløsning",
"source": "dkma",
"strength": "250 mg/ml",
"auth_role": "CMS",
"dk_drugid": "28106252319",
"substance": "Amikacinsulfat",
"auth_procedure": "Decentral procedure",
"in_medicinpriser": true,
"registration_date_serial": "44015"
}See everything about amikacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.